bryan johnson semaglutide microdosing liraglutide raised his resting heart rate by six to 10 bpm - peptide-uglies Olive Oil Is "Better Than Ozempic” Bryan Johnson and the Complex Relationship with Semaglutide: Exploring Longevity, Weight Loss, and Emerging Concerns

tb500-sleep The intersection of cutting-edge biohacking, longevity aspirations, and the growing popularity of weight-loss medications like semaglutide has brought figures like Bryan Johnson into the spotlight. Johnson, a tech entrepreneur known for his radical anti-aging regimen, has reportedly experimented with semaglutide and related GLP-1 RAs as part of his quest to rewind biological age. This exploration delves into the nuances of Bryan Johnson's use of these drugs, the scientific understanding of their effects, and the potential benefits and drawbacks.

Bryan Johnson's Longevity Pursuit and Semaglutide

Bryan Johnson's ambitious "Project Blueprint" aims to achieve the physical and cognitive state of an 18-year-old. As part of this extensive and highly publicized endeavor, he has engaged with various medical interventions and biohacking strategies. His interest in semaglutide, a GLP-1 RA (Glucagon-Like Peptide-1 Receptor Agonist), stems from its known effects on weight loss and metabolic health, which are often considered crucial components of aging well.

Semaglutide and other GLP-1 RAs, such as liraglutide and tirzepatide, function by mimicking natural hormones that regulate appetite and blood sugar. They help individuals feel fuller for longer, reduce cravings, and can lead to significant weight loss. Studies have indicated that semaglutide's clear benefit was metabolic, and in one instance, it reduced visceral fat by about 30% and total body fat by 19%. This metabolic impact is a key area of interest for those focused on longevity, as excess body fat, particularly visceral fat, is linked to various chronic diseases.

Johnson has reportedly experimented with "microdosing" these drugsIn that studysemaglutide's clear benefit was metabolic: it shrank visceral fat by about 30% and cut total body fat by 19%. Only after this .... In one account, he claimed that microdosing liraglutide raised his resting heart rate by six to 10 bpm, while semaglutide increased it by two to four bpm. This observation highlights a known side effect of GLP-1 RAs: an elevation in resting heart rate, which can range from an average of 2–10 beats per minute (bpm) for GLP-1RAs, such as semaglutide, liraglutide, and tirzepatide. This increase in heart rate has also been a point of concern, with some reporting that it can degrade sleep quality. For instance, one individual noted their resting rate looking like a mountain after starting semaglutide, with an increase of around 10 bpm in four months.2025年10月8日—Johnson claimedmicrodosing liraglutide raised his resting heart rate by six to 10 bpm. Semaglutide increased it by two to four bpm. Johnson ...

The concept of microdosing weight-loss drugs has even been touted for extending longevity by ultra-wealthy elites like tech entrepreneur Bryan Johnson. However, the long-term implications of such practices, especially in individuals not necessarily seeking significant weight loss but rather general anti-aging benefits, are still under investigationSchool of Medicine - CU Anschutz newsroom.

Beyond Weight Loss: The Longevity Debate

Can semaglutide slow aging? This question is gaining traction, fueled by early research and anecdotal evidence from figures like Bryan Johnson.Bryan Johnson Spent Millions To Be 18 Again—Says Novo ... A new study even shows low-dose GLP-1 RA reverses functional and molecular signs of aging in mice. This research, decoupled from body weight and food intake, suggests potential direct anti-aging mechanisms.3/ Possible Chronic Disease Risk Reduction Cardiovascular Health:semaglutide a GLP-1-RAhas shown promise of lifespan extension in obese ... The idea that these medications could be the first longevity drug is a tantalizing prospect for many in the scientific and biohacking communities. This includes discussions among longevity thought-leaders on social media, with comments from individuals like Bryan Johnson and Peter Diamandis.

However, the scientific community remains cautious. While semaglutide a GLP-1-RA has shown promise of lifespan extension in obese and diabetic individuals, its direct impact on aging in otherwise healthy populations requires more robust investigation. Concerns with Semaglutide and Other GLP-1 Receptor Agonists are valid and multifaceted, encompassing potential side effects and the need for long-term safety data.

Bryan Johnson's personal journey also includes exploring alternative perspectivesGLP-1's raise your resting rate which can degrade sleep .... While he has experimented with these drugs, sources suggest he has also commented that "Olive Oil Is 'Better Than Ozempic'," indicating a broader and perhaps evolving view on the optimal path to longevity. His regimen is known for its complexity, involving the consumption of 54 pills for breakfast and even controversial procedures like removing all plasma from his body for a new longevity treatment.Ozempic weight loss plateau: What is it and how to get past it

Navigating the Landscape: Experts, Side Effects, and the Future

The rise of semaglutide and similar drugs is undeniable, leading to discussions about their broader applications. The potential for an "Ozempic weight loss plateau" is a recognized phenomenon, requiring strategy adjustments for those using it for weight management. Celebrities like Kim Kardashian have also brought Semaglutide into public consciousness for its reported effects on weight loss.

For Biohacker Bryan Johnson, the exploration of semaglutide drugs is part of a larger, multi-million-dollar effort to understand and defy aging.2025年10月8日—Johnson claimedmicrodosing liraglutide raised his resting heart rate by six to 10 bpm. Semaglutide increased it by two to four bpm. Johnson ... His approach, which has been subject to scrutiny, with the New York Times accusing him of covering up side effects during trials of his supplements, underscores the importance of transparency and rigorous scientific validation.

The medical landscape is constantly evolving, with ongoing research into semaglutide's potential benefits and risks.Concerns with Semaglutide and Other GLP-1 Receptor Agonists While semaglutide's clear benefit was metabolic, and it demonstrably aids in weight loss and blood sugar management, its role as a "longevity drug" is still in its nascent stages of exploration. The intense focus on Bryan Johnson and his experimental use of these medications highlights the public's fascination with defying aging and the brave new world of pharmaceutical interventions in that pursuit. As more data emerges, the understanding of semaglutide and its place in health and longevity will undoubtedly continue to develop.School of Medicine - CU Anschutz newsroom